Christian S. Schade - 10 Jul 2023 Form 4/A Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Christian S. Schade
Issuer symbol
OMGAQ
Transactions as of
10 Jul 2023
Net transactions value
$0
Form type
4/A
Filing time
09 Feb 2024, 17:00:27 UTC
Date Of Original Report
12 Jul 2023
Previous filing
16 May 2023
Next filing
09 Feb 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OMGA Stock Option (Right to Buy) Award $0 +36,713 $0.000000 36,713 10 Jul 2023 Common Stock 36,713 $4.69 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in thirty-six substantially equal monthly installments following the date of grant, such that the option shall be fully vested and exercisable on the third anniversary of the date of grant, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such vesting date.

Remarks:

This Form 4 is being filed to correct the expiration date of the option in column 6 of Table II.